{"parse":{"title":"Epoxydocosapentaenoic acid","pageid":49599350,"revid":776740264,"text":{"*":"<div class=\"mw-parser-output\"><p><b>Epoxide docosapentaenoic acids</b> (<b>epoxydocosapentaenoic acids</b>, <b>EDPs</b>, or <b>EpDPEs</b>) are metabolites of the 22-carbon straight-chain <a href=\"/wiki/Omega-3_fatty_acid\" title=\"Omega-3 fatty acid\">omega-3 fatty acid</a>, <a href=\"/wiki/Docosahexaenoic_acid\" title=\"Docosahexaenoic acid\">docosahexaenoic acid</a> (DHA).  Cell types that express certain cytochrome P450 (CYP) <a href=\"/wiki/Epoxygenase\" title=\"Epoxygenase\">epoxygenases</a> metabolize <a href=\"/wiki/Polyunsaturated_fatty_acid\" title=\"Polyunsaturated fatty acid\">polyunsaturated fatty acid</a>'s (PUFAs) by converting one of their double bonds to an <a href=\"/wiki/Epoxide\" title=\"Epoxide\">epoxide</a>.  In the best known of these metabolic pathways, cellular CYP epoxygenases metabolize the 20-carbon straight-chain <a href=\"/wiki/Omega-6_fatty_acid\" title=\"Omega-6 fatty acid\">omega-6 fatty acid</a>, <a href=\"/wiki/Arachidonic_acid\" title=\"Arachidonic acid\">arachidonic acid</a>, to <a href=\"/wiki/Epoxyeicosatrienoic_acid\" title=\"Epoxyeicosatrienoic acid\">epoxyeicosatrienoic acids</a> (EETs); another CYP epoxygenase pathway metabolizes the  20-carbon omega-3 fatty acid, <a href=\"/wiki/Eicosapentaenoic_acid\" title=\"Eicosapentaenoic acid\">eicosapentaenoic acid</a> (EPA), to <a href=\"/wiki/Epoxyeicosatetraenoic_acid\" title=\"Epoxyeicosatetraenoic acid\">epoxyeicosatetraenoic acids</a> (EEQs). CYP epoxygenases similarly convert various other PUFAs to epoxides (see <a href=\"/wiki/Epoxygenase\" title=\"Epoxygenase\">epoxygenase</a>) These epoxide metabolites have a variety of activities.  However, essentially all of them are rapidly converted to their corresponding, but in general far less active, <a href=\"/wiki/Vicinal_(chemistry)\" title=\"Vicinal (chemistry)\">Vicinal (chemistry)</a> dihydroxy fatty acids by ubiquitous cellular <a href=\"/wiki/Soluble_epoxide_hydrolase\" class=\"mw-redirect\" title=\"Soluble epoxide hydrolase\">Soluble epoxide hydrolase</a> (sEH; also termed Epoxide hydrolase 2).  Consequently, these epoxides, including EDPs, operate as short-lived signaling agents that regulate the function of their parent or nearby cells.  The particular feature of EDPs (and EEQs) distinguishing them from EETs is that they derive from omega-3 fatty acids and are suggested to be responsible for some of the  beneficial effects attributed to omega-3 fatty acids and omega-3-rich foods such as <a href=\"/wiki/Fish_oil\" title=\"Fish oil\">fish oil</a>.<sup id=\"cite_ref-ReferenceA_1-0\" class=\"reference\"><a href=\"#cite_note-ReferenceA-1\">&#91;1&#93;</a></sup>\n</p>\n<div id=\"toc\" class=\"toc\"><input type=\"checkbox\" role=\"button\" id=\"toctogglecheckbox\" class=\"toctogglecheckbox\" style=\"display:none\" /><div class=\"toctitle\" lang=\"en\" dir=\"ltr\"><h2>Contents</h2><span class=\"toctogglespan\"><label class=\"toctogglelabel\" for=\"toctogglecheckbox\"></label></span></div>\n<ul>\n<li class=\"toclevel-1 tocsection-1\"><a href=\"#Structure\"><span class=\"tocnumber\">1</span> <span class=\"toctext\">Structure</span></a></li>\n<li class=\"toclevel-1 tocsection-2\"><a href=\"#Production\"><span class=\"tocnumber\">2</span> <span class=\"toctext\">Production</span></a></li>\n<li class=\"toclevel-1 tocsection-3\"><a href=\"#EDP_metabolism\"><span class=\"tocnumber\">3</span> <span class=\"toctext\">EDP metabolism</span></a></li>\n<li class=\"toclevel-1 tocsection-4\"><a href=\"#Clinical_significance\"><span class=\"tocnumber\">4</span> <span class=\"toctext\">Clinical significance</span></a></li>\n<li class=\"toclevel-1 tocsection-5\"><a href=\"#References\"><span class=\"tocnumber\">5</span> <span class=\"toctext\">References</span></a></li>\n</ul>\n</div>\n\n<h2><span class=\"mw-headline\" id=\"Structure\">Structure</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Epoxydocosapentaenoic_acid&amp;action=edit&amp;section=1\" title=\"Edit section: Structure\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>EDPs are <a href=\"/wiki/Epoxide\" title=\"Epoxide\">epoxide</a> eicosapentaenoic acid metabolites of DHA.  DHA has 6 cis (see <a href=\"/wiki/Cis%E2%80%93trans_isomerism\" title=\"Cis\u2013trans isomerism\">Cis\u2013trans isomerism</a>) <a href=\"/wiki/Double_bond\" title=\"Double bond\">Double bonds</a> each one of which is located between carbons 4-5, 7-8, 10-11, 13-14, 16-17, or 19-20. Cytochrome P450 epoxygenases attack any one of these double bounds to form a respective docosapentaenoic acid (DPA) epoxide regioisomer (see <a href=\"/wiki/Structural_isomer\" title=\"Structural isomer\">Structural isomer</a>, section on position isomerism (regioisomerism)).  A given epoxygenase may therefore convert DHA to 4,5-EDP (i.e. 4,5-epoxy-7<i>Z</i>,10<i>Z</i>,13<i>Z</i>,16<i>Z</i>,19<i>Z</i>-DPA), 7,8-EDP (i.e. 7,8-epoxy-4<i>Z</i>,10<i>Z</i>,13<i>Z</i>,16<i>Z</i>,19<i>Z</i>-DPA), 10,11-EDP (i.e. 10,11-epoxy-4<i>Z</i>,7<i>Z</i>,13<i>Z</i>,16<i>Z</i>,19<i>Z</i>-DPA), 13,14-EDP (i.e. 13,14-epoxy-4<i>Z</i>,7<i>Z</i>,10<i>Z</i>,16<i>Z</i>,19<i>Z</i>-DPA), 16,17-EDP (i.e. 16,17-epoxy-4<i>Z</i>,7<i>Z</i>,10<i>Z</i>,13<i>Z</i>,19<i>Z</i>-DPA, or 19,20-EDP (i.e. 19,20-epoxy-4<i>Z</i>, 7<i>Z</i>,10<i>Z</i>,13<i>Z</i>,16<i>Z</i>-DPA. The epoxygenase enzymes generally form both <i>R</i>/<i>S</i> <a href=\"/wiki/Enantiomers\" class=\"mw-redirect\" title=\"Enantiomers\">enantiomers</a> at each former double bound position; for example, cytochrome P450 epoxidases attack DHA at the 16,17-double bond position to form two epoxide enantiomers, 16<i>R</i>,17<i>S</i>-EDP and 16<i>S</i>,15<i>17</i>-EDP.<sup id=\"cite_ref-Biochim_Biophys_Acta_2014_2-0\" class=\"reference\"><a href=\"#cite_note-Biochim_Biophys_Acta_2014-2\">&#91;2&#93;</a></sup>  The 4,5-EDP metabolite is unstable and generally not detected among the EDP formed by cells.<sup id=\"cite_ref-Prog_Lipid_Res_2013_3-0\" class=\"reference\"><a href=\"#cite_note-Prog_Lipid_Res_2013-3\">&#91;3&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Production\">Production</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Epoxydocosapentaenoic_acid&amp;action=edit&amp;section=2\" title=\"Edit section: Production\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Enzymes of the cytochrome P450 (CYP) superfamily that are classified as epoxygenases based on their ability to metabolize PUFA, particularly arachidonic acid, to epoxides include: CYP1A, CYP2B, CYP2C, CYP2E, CYP2J, and within the CYP3A subfamily, CYP3A4. In humans, <a href=\"/wiki/CYP2C8\" title=\"CYP2C8\">CYP2C8</a>, <a href=\"/wiki/CYP2C9\" title=\"CYP2C9\">CYP2C9</a>, <a href=\"/wiki/CYP2C19\" title=\"CYP2C19\">CYP2C19</a>, <a href=\"/wiki/CYP2J2\" title=\"CYP2J2\">CYP2J2</a>, and possibly <a href=\"/wiki/CYP2S1\" title=\"CYP2S1\">CYP2S1</a> <a href=\"/wiki/Isoforms\" class=\"mw-redirect\" title=\"Isoforms\">isoforms</a> appear to be the principal epoxygenases responsible for metabolizing arachidonic acid to EETs (see <a href=\"/wiki/Epoxyeicosatrienoic_acid#Production\" title=\"Epoxyeicosatrienoic acid\">Epoxyeicosatrienoic acid#Production</a>).  In general, these same CYP epoxygenases also metabolize DHA to EDP (as well as EPA to EEQ; CYP2S1 has not yet been tested for DHA-metabolizing ability), doing so at rates that are often greater than their rates in metabolizing arachidonic acid to EETs; that is, DHA (and EPA) appear to be preferred over arachidonic acid as substrates for many of the CYP epoxygenases.<sup id=\"cite_ref-4\" class=\"reference\"><a href=\"#cite_note-4\">&#91;4&#93;</a></sup>  <a href=\"/wiki/CYP1A1\" class=\"mw-redirect\" title=\"CYP1A1\">CYP1A1</a>, <a href=\"/wiki/CYP1A2\" title=\"CYP1A2\">CYP1A2</a>, <a href=\"/wiki/CYP2C18\" title=\"CYP2C18\">CYP2C18</a>, <a href=\"/wiki/CYP2E1\" title=\"CYP2E1\">CYP2E1</a>, <a href=\"/wiki/CYP4A11\" title=\"CYP4A11\">CYP4A11</a>, <a href=\"/wiki/CYP4F8\" title=\"CYP4F8\">CYP4F8</a>, and <a href=\"/wiki/CYP4F12\" title=\"CYP4F12\">CYP4F12</a> also metabolize DHA to EDPs.<sup id=\"cite_ref-Prostaglandins_Other_Lipid_Mediat_2011._p_16_5-0\" class=\"reference\"><a href=\"#cite_note-Prostaglandins_Other_Lipid_Mediat_2011._p_16-5\">&#91;5&#93;</a></sup>  CYP2C8, CYP2C18, CYP2E1, CYP2J2, VYP4A11, CYP4F8, and CYP4F12 preferentially attack the terminal omega-3 double bond that distinguishes DHA from omega-6 fatty acids and therefore metabolize DHA principally to 19,20-EDP isomers while <a href=\"/wiki/CYP2C19\" title=\"CYP2C19\">CYP2C19</a> metabolizes DHA to 7,8-EDP, 10,11-EDP, and 19,20-EDP isomers<sup id=\"cite_ref-Prostaglandins_Other_Lipid_Mediat_2011._p_16_5-1\" class=\"reference\"><a href=\"#cite_note-Prostaglandins_Other_Lipid_Mediat_2011._p_16-5\">&#91;5&#93;</a></sup><sup id=\"cite_ref-6\" class=\"reference\"><a href=\"#cite_note-6\">&#91;6&#93;</a></sup>  CYP2J2 metabolizes DHA to EPAs, principally 19,20-EPA, at twice the rate that it metabolizes arachidonic acid to EETs.<sup id=\"cite_ref-7\" class=\"reference\"><a href=\"#cite_note-7\">&#91;7&#93;</a></sup> In addition to the cited CYP's, <a href=\"/wiki/CYP4A11\" title=\"CYP4A11\">CYP4A11</a>, <a href=\"/wiki/CYP4F8\" title=\"CYP4F8\">CYP4F8</a>, <a href=\"/wiki/CYP4F12\" title=\"CYP4F12\">CYP4F12</a>, <a href=\"/wiki/CYP1A1\" class=\"mw-redirect\" title=\"CYP1A1\">CYP1A1</a>, <a href=\"/wiki/CYP1A2\" title=\"CYP1A2\">CYP1A2</a>, and <a href=\"/wiki/CYP2E1\" title=\"CYP2E1\">CYP2E1</a>, which are classified as CYP monooxygenase rather than CYP epoxygeanses because they metablize arachidonic acid to monohydroxy eicosatetraenoic acids (see <a href=\"/wiki/20-Hydroxyeicosatetraenoic_acid\" title=\"20-Hydroxyeicosatetraenoic acid\">20-Hydroxyeicosatetraenoic acid</a>), i.e. 19-hydroxyeicosatetraenoic acid and/or 20-hydroxyeicosatetranoic acid, take on epoxygease activity in converting DHA primarily to 19,20-EDP isomers (see <a href=\"/wiki/Epoxyeicosatrienoic_acid\" title=\"Epoxyeicosatrienoic acid\">epoxyeicosatrienoic acid</a>).<sup id=\"cite_ref-Prostaglandins_Other_Lipid_Mediat_2011._p_16_5-2\" class=\"reference\"><a href=\"#cite_note-Prostaglandins_Other_Lipid_Mediat_2011._p_16-5\">&#91;5&#93;</a></sup> The CYP450 epoxygenases capable of metabolizing DHA to EDPs are wildly distributed in organs and tissues such as the liver, kidney, heart, lung, pancreas, intestine, blood vessels, blood leukocytes, and brain.<sup id=\"cite_ref-8\" class=\"reference\"><a href=\"#cite_note-8\">&#91;8&#93;</a></sup><sup id=\"cite_ref-9\" class=\"reference\"><a href=\"#cite_note-9\">&#91;9&#93;</a></sup>  These tissues are known to metabolize arachidonic acid to EETs; it has been shown or is presumed that they also metabolize DHA to EPD's.\n</p><p>The EDPs are commonly made by the stimulation of specific cell types by the same mechanisms which produce EETs (see <a href=\"/wiki/Epoxyeicosatrienoic_acid\" title=\"Epoxyeicosatrienoic acid\">Epoxyeicosatrienoic acid</a>).  That is, cell stimulation causes DHA to be released from the <i>sn-2</i> position of their membrane-bound cellular <a href=\"/wiki/Phospholipid\" title=\"Phospholipid\">phospholipid</a> pools through the action of a <a href=\"/wiki/Phospholipase_A2\" title=\"Phospholipase A2\">Phospholipase A2</a>-type enzyme and the subsequent attack of the released DHA by CYP450 epoxidases. It is notable that the consumption of omega-3 fatty acid-rich diets dramatically raises the serum and tissue levels of EDPs and EEQs in animals as well as humans.  Indeed, this rise in EDP (and EEQ) levels in humans is by far the most prominent change in the profile of PUFA metabolites caused by dietary omega-3 fatty acids and, it is suggested, may be responsible for at least some of the beneficial effects ascribed to dietary omega-3 fatty acids.<sup id=\"cite_ref-ReferenceA_1-1\" class=\"reference\"><a href=\"#cite_note-ReferenceA-1\">&#91;1&#93;</a></sup><sup id=\"cite_ref-J_Lipid_Res_1164_10-0\" class=\"reference\"><a href=\"#cite_note-J_Lipid_Res_1164-10\">&#91;10&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"EDP_metabolism\">EDP metabolism</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Epoxydocosapentaenoic_acid&amp;action=edit&amp;section=3\" title=\"Edit section: EDP metabolism\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Similar to EETs (see <a href=\"/wiki/Epoxyeicosatrienoic_acid\" title=\"Epoxyeicosatrienoic acid\">Epoxyeicosatrienoic acid</a>), EDPs are rapidly metabolized in cells by a cytosolic <a href=\"/wiki/Soluble_epoxide_hydrolase\" class=\"mw-redirect\" title=\"Soluble epoxide hydrolase\">soluble epoxide hydrolase</a> (sEH, also termed Epoxide hydrolase 2 [EC 3.2.2.10.]) to form their corresponding <a href=\"/wiki/Vicinal_(chemistry)\" title=\"Vicinal (chemistry)\">Vicinal (chemistry)</a> <a href=\"/wiki/Diol\" title=\"Diol\">diol</a> dihydroxyeicosapentaenoic acids. Thus, sEH converts 19,20-EDP to 19,10-dihdroxydocosapentaenoic acid (DPA), 16,17-EDP to 16,17-dihydroxy-DPA, 13,14-EDP to 13,14-dihydroxy-DPA, 10,11-EDP to 10,11-dihydroxy-DPA, and 7,8-EDP to 7,8-dihydroxy-EDP; 4,5-EDP is unstable and therefore generally not detected in cells.<sup id=\"cite_ref-Gene_p_10_11-0\" class=\"reference\"><a href=\"#cite_note-Gene_p_10-11\">&#91;11&#93;</a></sup> The dihydroxy-EDP products, like their epoxy precursors, are <a href=\"/wiki/Enantiomer\" title=\"Enantiomer\">enantiomer</a> mixtures; for instance, sEH converts 16,17-EDP to a mixture of 16(<i>S</i>),17(<i>R</i>)-dihydroxy-DPA and 16(<i>R</i>),1y(<i>S</i>)-dihydroxy-DPA.<sup id=\"cite_ref-Biochim_Biophys_Acta_2014_2-1\" class=\"reference\"><a href=\"#cite_note-Biochim_Biophys_Acta_2014-2\">&#91;2&#93;</a></sup> These dihydroxy-DPAs typically are far less active than their epoxide precursors.  The sEH pathway acts rapidly and is by far the predominant pathway of EDP inactivation; its operation causes EDPs to function as short-lived mediators whose actions are limited to their parent and nearby cells, i.e. they are <a href=\"/wiki/Autocrine\" class=\"mw-redirect\" title=\"Autocrine\">autocrine</a> and <a href=\"/wiki/Paracrine\" class=\"mw-redirect\" title=\"Paracrine\">paracrine</a> signaling agents, respectively.<sup id=\"cite_ref-Gene_p_10_11-1\" class=\"reference\"><a href=\"#cite_note-Gene_p_10-11\">&#91;11&#93;</a></sup><sup id=\"cite_ref-12\" class=\"reference\"><a href=\"#cite_note-12\">&#91;12&#93;</a></sup><sup id=\"cite_ref-ReferenceB_13-0\" class=\"reference\"><a href=\"#cite_note-ReferenceB-13\">&#91;13&#93;</a></sup>\n</p><p>In addition to the sEH pathway, EDPs, similar to the EETs, may be acylated into phospholipids in an <a href=\"/wiki/Acylation\" title=\"Acylation\">Acylation</a>-like reaction; this pathway may serve to limit the action of EETs or store them for future release.<sup id=\"cite_ref-Biochim_Biophys_Acta_2014_2-2\" class=\"reference\"><a href=\"#cite_note-Biochim_Biophys_Acta_2014-2\">&#91;2&#93;</a></sup>  Finally, again similar to the EETs, EDPs are subject to inactivation by being further metabolized b <a href=\"/wiki/Beta_oxidation\" title=\"Beta oxidation\">Beta oxidation</a>.<sup id=\"cite_ref-Prostaglandins_Other_Lipid_Mediat_2014._p_18_14-0\" class=\"reference\"><a href=\"#cite_note-Prostaglandins_Other_Lipid_Mediat_2014._p_18-14\">&#91;14&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Clinical_significance\">Clinical significance</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Epoxydocosapentaenoic_acid&amp;action=edit&amp;section=4\" title=\"Edit section: Clinical significance\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>EDPs have not be studied nearly as well as the EETs.  This is particularly the case for animal studies into their potential clinical significance.  In comparison to a selection of the many activities attributed to the EETs (see <a href=\"/wiki/Epoxyeicosatrienoic_acid\" title=\"Epoxyeicosatrienoic acid\">Epoxyeicosatrienoic acid</a>), animal studies reported to date find that certain EDPs (16,17-EDP and 19,20-EDP have been most often examined) are: <b>1)</b> more potent than EETs in decreasing hypertension and pain perception; <b>2)</b> more potent than or at least equal in potency to the EETs in suppressing inflammation; and <b>3)</b> act oppositely from the EETs in that EDPs inhibit <a href=\"/wiki/Angiogenesis\" title=\"Angiogenesis\">angiogenesis</a>, endothelial cell migration, endothelial cell proliferation, and the growth and metastasis of human breast and prostate cancer cell lines whereas EETs have stimulatory effects in each of these systems.<sup id=\"cite_ref-ReferenceA_1-2\" class=\"reference\"><a href=\"#cite_note-ReferenceA-1\">&#91;1&#93;</a></sup><sup id=\"cite_ref-Prog_Lipid_Res_2013_3-1\" class=\"reference\"><a href=\"#cite_note-Prog_Lipid_Res_2013-3\">&#91;3&#93;</a></sup><sup id=\"cite_ref-ReferenceB_13-1\" class=\"reference\"><a href=\"#cite_note-ReferenceB-13\">&#91;13&#93;</a></sup><sup id=\"cite_ref-Prostaglandins_Other_Lipid_Mediat_2014._p_18_14-1\" class=\"reference\"><a href=\"#cite_note-Prostaglandins_Other_Lipid_Mediat_2014._p_18-14\">&#91;14&#93;</a></sup> As indicated in the Metabolism section, consumption of omega-3 fatty acid-rich diets dramatically raises the serum and tissue levels of EDPs and EEQs in animals as well as humans and in humans is by far the most prominent change in the profile of PUFA metabolites caused by dietary omega-3 fatty acids. Hence, the metabolism of DHA to EDPs (and EPA to EEQs) may be responsible for at least some of the beneficial effects ascribed to dietary omega-3 fatty acids.<sup id=\"cite_ref-ReferenceA_1-3\" class=\"reference\"><a href=\"#cite_note-ReferenceA-1\">&#91;1&#93;</a></sup><sup id=\"cite_ref-J_Lipid_Res_1164_10-1\" class=\"reference\"><a href=\"#cite_note-J_Lipid_Res_1164-10\">&#91;10&#93;</a></sup><sup id=\"cite_ref-Prostaglandins_Other_Lipid_Mediat_2014._p_18_14-2\" class=\"reference\"><a href=\"#cite_note-Prostaglandins_Other_Lipid_Mediat_2014._p_18-14\">&#91;14&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"References\">References</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Epoxydocosapentaenoic_acid&amp;action=edit&amp;section=5\" title=\"Edit section: References\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"reflist\" style=\"list-style-type: decimal;\">\n<div class=\"mw-references-wrap mw-references-columns\"><ol class=\"references\">\n<li id=\"cite_note-ReferenceA-1\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-ReferenceA_1-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-ReferenceA_1-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-ReferenceA_1-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-ReferenceA_1-3\"><sup><i><b>d</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Fleming, I (2014). \"The pharmacology of the cytochrome P450 epoxygenase/soluble epoxide hydrolase axis in the vasculature and cardiovascular disease\". <i>Pharmacological Reviews</i>. <b>66</b> (4): 1106\u201340. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1124/pr.113.007781\">10.1124/pr.113.007781</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/25244930\">25244930</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Pharmacological+Reviews&amp;rft.atitle=The+pharmacology+of+the+cytochrome+P450+epoxygenase%2Fsoluble+epoxide+hydrolase+axis+in+the+vasculature+and+cardiovascular+disease&amp;rft.volume=66&amp;rft.issue=4&amp;rft.pages=1106-40&amp;rft.date=2014&amp;rft_id=info%3Adoi%2F10.1124%2Fpr.113.007781&amp;rft_id=info%3Apmid%2F25244930&amp;rft.aulast=Fleming&amp;rft.aufirst=I&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxydocosapentaenoic+acid\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Biochim_Biophys_Acta_2014-2\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Biochim_Biophys_Acta_2014_2-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Biochim_Biophys_Acta_2014_2-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Biochim_Biophys_Acta_2014_2-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Spector, A. A.; Kim, H. Y. (2015). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4314516\">\"Cytochrome P450 epoxygenase pathway of polyunsaturated fatty acid metabolism\"</a>. <i>Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids</i>. <b>1851</b> (4): 356\u201365. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.bbalip.2014.07.020\">10.1016/j.bbalip.2014.07.020</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4314516\">4314516</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/25093613\">25093613</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Biochimica+et+Biophysica+Acta+%28BBA%29+-+Molecular+and+Cell+Biology+of+Lipids&amp;rft.atitle=Cytochrome+P450+epoxygenase+pathway+of+polyunsaturated+fatty+acid+metabolism&amp;rft.volume=1851&amp;rft.issue=4&amp;rft.pages=356-65&amp;rft.date=2015&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4314516&amp;rft_id=info%3Apmid%2F25093613&amp;rft_id=info%3Adoi%2F10.1016%2Fj.bbalip.2014.07.020&amp;rft.aulast=Spector&amp;rft.aufirst=A.+A.&amp;rft.au=Kim%2C+H.+Y.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4314516&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxydocosapentaenoic+acid\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Prog_Lipid_Res_2013-3\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Prog_Lipid_Res_2013_3-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Prog_Lipid_Res_2013_3-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Zhang, G; Kodani, S; Hammock, B. D. (2014). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3914417\">\"Stabilized epoxygenated fatty acids regulate inflammation, pain, angiogenesis and cancer\"</a>. <i>Progress in Lipid Research</i>. <b>53</b>: 108\u201323. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.plipres.2013.11.003\">10.1016/j.plipres.2013.11.003</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3914417\">3914417</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/24345640\">24345640</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Progress+in+Lipid+Research&amp;rft.atitle=Stabilized+epoxygenated+fatty+acids+regulate+inflammation%2C+pain%2C+angiogenesis+and+cancer&amp;rft.volume=53&amp;rft.pages=108-23&amp;rft.date=2014&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3914417&amp;rft_id=info%3Apmid%2F24345640&amp;rft_id=info%3Adoi%2F10.1016%2Fj.plipres.2013.11.003&amp;rft.aulast=Zhang&amp;rft.aufirst=G&amp;rft.au=Kodani%2C+S&amp;rft.au=Hammock%2C+B.+D.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3914417&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxydocosapentaenoic+acid\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-4\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-4\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Fr\u00f6mel, T; Fleming, I (2015). \"Whatever happened to the epoxyeicosatrienoic Acid-like endothelium-derived hyperpolarizing factor? The identification of novel classes of lipid mediators and their role in vascular homeostasis\". <i>Antioxidants &amp; Redox Signaling</i>. <b>22</b> (14): 1273\u201392. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1089/ars.2014.6150\">10.1089/ars.2014.6150</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/25330284\">25330284</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Antioxidants+%26+Redox+Signaling&amp;rft.atitle=Whatever+happened+to+the+epoxyeicosatrienoic+Acid-like+endothelium-derived+hyperpolarizing+factor%3F+The+identification+of+novel+classes+of+lipid+mediators+and+their+role+in+vascular+homeostasis&amp;rft.volume=22&amp;rft.issue=14&amp;rft.pages=1273-92&amp;rft.date=2015&amp;rft_id=info%3Adoi%2F10.1089%2Fars.2014.6150&amp;rft_id=info%3Apmid%2F25330284&amp;rft.aulast=Fr%C3%B6mel&amp;rft.aufirst=T&amp;rft.au=Fleming%2C+I&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxydocosapentaenoic+acid\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Prostaglandins_Other_Lipid_Mediat_2011._p_16-5\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Prostaglandins_Other_Lipid_Mediat_2011._p_16_5-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Prostaglandins_Other_Lipid_Mediat_2011._p_16_5-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Prostaglandins_Other_Lipid_Mediat_2011._p_16_5-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Westphal, C; Konkel, A; Schunck, W. H. (2011). \"CYP-eicosanoids--a new link between omega-3 fatty acids and cardiac disease?\". <i>Prostaglandins &amp; Other Lipid Mediators</i>. <b>96</b> (1\u20134): 99\u2013108. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.prostaglandins.2011.09.001\">10.1016/j.prostaglandins.2011.09.001</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/21945326\">21945326</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Prostaglandins+%26+Other+Lipid+Mediators&amp;rft.atitle=CYP-eicosanoids--a+new+link+between+omega-3+fatty+acids+and+cardiac+disease%3F&amp;rft.volume=96&amp;rft.issue=1%E2%80%934&amp;rft.pages=99-108&amp;rft.date=2011&amp;rft_id=info%3Adoi%2F10.1016%2Fj.prostaglandins.2011.09.001&amp;rft_id=info%3Apmid%2F21945326&amp;rft.aulast=Westphal&amp;rft.aufirst=C&amp;rft.au=Konkel%2C+A&amp;rft.au=Schunck%2C+W.+H.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxydocosapentaenoic+acid\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-6\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-6\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Fer, M; Dr\u00e9ano, Y; Lucas, D; Corcos, L; Sala\u00fcn, J. P.; Berthou, F; Amet, Y (2008). \"Metabolism of eicosapentaenoic and docosahexaenoic acids by recombinant human cytochromes P450\". <i>Archives of Biochemistry and Biophysics</i>. <b>471</b> (2): 116\u201325. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.abb.2008.01.002\">10.1016/j.abb.2008.01.002</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/18206980\">18206980</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Archives+of+Biochemistry+and+Biophysics&amp;rft.atitle=Metabolism+of+eicosapentaenoic+and+docosahexaenoic+acids+by+recombinant+human+cytochromes+P450&amp;rft.volume=471&amp;rft.issue=2&amp;rft.pages=116-25&amp;rft.date=2008&amp;rft_id=info%3Adoi%2F10.1016%2Fj.abb.2008.01.002&amp;rft_id=info%3Apmid%2F18206980&amp;rft.aulast=Fer&amp;rft.aufirst=M&amp;rft.au=Dr%C3%A9ano%2C+Y&amp;rft.au=Lucas%2C+D&amp;rft.au=Corcos%2C+L&amp;rft.au=Sala%C3%BCn%2C+J.+P.&amp;rft.au=Berthou%2C+F&amp;rft.au=Amet%2C+Y&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxydocosapentaenoic+acid\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-7\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-7\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Konkel, A; Schunck, W. H. (2011). \"Role of cytochrome P450 enzymes in the bioactivation of polyunsaturated fatty acids\". <i>Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics</i>. <b>1814</b> (1): 210\u201322. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.bbapap.2010.09.009\">10.1016/j.bbapap.2010.09.009</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/20869469\">20869469</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Biochimica+et+Biophysica+Acta+%28BBA%29+-+Proteins+and+Proteomics&amp;rft.atitle=Role+of+cytochrome+P450+enzymes+in+the+bioactivation+of+polyunsaturated+fatty+acids&amp;rft.volume=1814&amp;rft.issue=1&amp;rft.pages=210-22&amp;rft.date=2011&amp;rft_id=info%3Adoi%2F10.1016%2Fj.bbapap.2010.09.009&amp;rft_id=info%3Apmid%2F20869469&amp;rft.aulast=Konkel&amp;rft.aufirst=A&amp;rft.au=Schunck%2C+W.+H.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxydocosapentaenoic+acid\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-8\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-8\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Spector, A. A. (2009). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2674692\">\"Arachidonic acid cytochrome P450 epoxygenase pathway\"</a>. <i>The Journal of Lipid Research</i>. 50 Suppl: S52\u20136. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1194/jlr.R800038-JLR200\">10.1194/jlr.R800038-JLR200</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2674692\">2674692</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/18952572\">18952572</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Journal+of+Lipid+Research&amp;rft.atitle=Arachidonic+acid+cytochrome+P450+epoxygenase+pathway&amp;rft.volume=50+Suppl&amp;rft.pages=S52-6&amp;rft.date=2009&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2674692&amp;rft_id=info%3Apmid%2F18952572&amp;rft_id=info%3Adoi%2F10.1194%2Fjlr.R800038-JLR200&amp;rft.aulast=Spector&amp;rft.aufirst=A.+A.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2674692&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxydocosapentaenoic+acid\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-9\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-9\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Xu, M; Ju, W; Hao, H; Wang, G; Li, P (2013). \"Cytochrome P450 2J2: Distribution, function, regulation, genetic polymorphisms and clinical significance\". <i>Drug Metabolism Reviews</i>. <b>45</b> (3): 311\u201352. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.3109/03602532.2013.806537\">10.3109/03602532.2013.806537</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/23865864\">23865864</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Drug+Metabolism+Reviews&amp;rft.atitle=Cytochrome+P450+2J2%3A+Distribution%2C+function%2C+regulation%2C+genetic+polymorphisms+and+clinical+significance&amp;rft.volume=45&amp;rft.issue=3&amp;rft.pages=311-52&amp;rft.date=2013&amp;rft_id=info%3Adoi%2F10.3109%2F03602532.2013.806537&amp;rft_id=info%3Apmid%2F23865864&amp;rft.aulast=Xu&amp;rft.aufirst=M&amp;rft.au=Ju%2C+W&amp;rft.au=Hao%2C+H&amp;rft.au=Wang%2C+G&amp;rft.au=Li%2C+P&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxydocosapentaenoic+acid\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-J_Lipid_Res_1164-10\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-J_Lipid_Res_1164_10-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-J_Lipid_Res_1164_10-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Fischer, R; Konkel, A; Mehling, H; Blossey, K; Gapelyuk, A; Wessel, N; von Schacky, C; Dechend, R; Muller, D. N.; Rothe, M; Luft, F. C.; Weylandt, K; Schunck, W. H. (2014). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4031946\">\"Dietary omega-3 fatty acids modulate the eicosanoid profile in man primarily via the CYP-epoxygenase pathway\"</a>. <i>The Journal of Lipid Research</i>. <b>55</b> (6): 1150\u20131164. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1194/jlr.M047357\">10.1194/jlr.M047357</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4031946\">4031946</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/24634501\">24634501</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Journal+of+Lipid+Research&amp;rft.atitle=Dietary+omega-3+fatty+acids+modulate+the+eicosanoid+profile+in+man+primarily+via+the+CYP-epoxygenase+pathway&amp;rft.volume=55&amp;rft.issue=6&amp;rft.pages=1150-1164&amp;rft.date=2014&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4031946&amp;rft_id=info%3Apmid%2F24634501&amp;rft_id=info%3Adoi%2F10.1194%2Fjlr.M047357&amp;rft.aulast=Fischer&amp;rft.aufirst=R&amp;rft.au=Konkel%2C+A&amp;rft.au=Mehling%2C+H&amp;rft.au=Blossey%2C+K&amp;rft.au=Gapelyuk%2C+A&amp;rft.au=Wessel%2C+N&amp;rft.au=von+Schacky%2C+C&amp;rft.au=Dechend%2C+R&amp;rft.au=Muller%2C+D.+N.&amp;rft.au=Rothe%2C+M&amp;rft.au=Luft%2C+F.+C.&amp;rft.au=Weylandt%2C+K&amp;rft.au=Schunck%2C+W.+H.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4031946&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxydocosapentaenoic+acid\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Gene_p_10-11\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Gene_p_10_11-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Gene_p_10_11-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Harris, T. R.; Hammock, B. D. (2013). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3733540\">\"Soluble epoxide hydrolase: Gene structure, expression and deletion\"</a>. <i>Gene</i>. <b>526</b> (2): 61\u201374. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.gene.2013.05.008\">10.1016/j.gene.2013.05.008</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3733540\">3733540</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/23701967\">23701967</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Gene&amp;rft.atitle=Soluble+epoxide+hydrolase%3A+Gene+structure%2C+expression+and+deletion&amp;rft.volume=526&amp;rft.issue=2&amp;rft.pages=61-74&amp;rft.date=2013&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3733540&amp;rft_id=info%3Apmid%2F23701967&amp;rft_id=info%3Adoi%2F10.1016%2Fj.gene.2013.05.008&amp;rft.aulast=Harris&amp;rft.aufirst=T.+R.&amp;rft.au=Hammock%2C+B.+D.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3733540&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxydocosapentaenoic+acid\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-12\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-12\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Bellien, J; Joannides, R (2013). \"Epoxyeicosatrienoic acid pathway in human health and diseases\". <i>Journal of Cardiovascular Pharmacology</i>. <b>61</b> (3): 188\u201396. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1097/FJC.0b013e318273b007\">10.1097/FJC.0b013e318273b007</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/23011468\">23011468</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Cardiovascular+Pharmacology&amp;rft.atitle=Epoxyeicosatrienoic+acid+pathway+in+human+health+and+diseases&amp;rft.volume=61&amp;rft.issue=3&amp;rft.pages=188-96&amp;rft.date=2013&amp;rft_id=info%3Adoi%2F10.1097%2FFJC.0b013e318273b007&amp;rft_id=info%3Apmid%2F23011468&amp;rft.aulast=Bellien&amp;rft.aufirst=J&amp;rft.au=Joannides%2C+R&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxydocosapentaenoic+acid\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-ReferenceB-13\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-ReferenceB_13-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-ReferenceB_13-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">He, J; Wang, C; Zhu, Y; Ai, D (2016). \"Soluble epoxide hydrolase: A potential target for metabolic diseases\". <i>Journal of Diabetes</i>. <b>8</b> (3): 305\u201313. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1111/1753-0407.12358\">10.1111/1753-0407.12358</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/26621325\">26621325</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Diabetes&amp;rft.atitle=Soluble+epoxide+hydrolase%3A+A+potential+target+for+metabolic+diseases&amp;rft.volume=8&amp;rft.issue=3&amp;rft.pages=305-13&amp;rft.date=2016&amp;rft_id=info%3Adoi%2F10.1111%2F1753-0407.12358&amp;rft_id=info%3Apmid%2F26621325&amp;rft.aulast=He&amp;rft.aufirst=J&amp;rft.au=Wang%2C+C&amp;rft.au=Zhu%2C+Y&amp;rft.au=Ai%2C+D&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxydocosapentaenoic+acid\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Prostaglandins_Other_Lipid_Mediat_2014._p_18-14\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Prostaglandins_Other_Lipid_Mediat_2014._p_18_14-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Prostaglandins_Other_Lipid_Mediat_2014._p_18_14-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Prostaglandins_Other_Lipid_Mediat_2014._p_18_14-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Wagner, K; Vito, S; Inceoglu, B; Hammock, B. D. (2014). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4254344\">\"The role of long chain fatty acids and their epoxide metabolites in nociceptive signaling\"</a>. <i>Prostaglandins &amp; Other Lipid Mediators</i>. 113-115: 2\u201312. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.prostaglandins.2014.09.001\">10.1016/j.prostaglandins.2014.09.001</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4254344\">4254344</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/25240260\">25240260</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Prostaglandins+%26+Other+Lipid+Mediators&amp;rft.atitle=The+role+of+long+chain+fatty+acids+and+their+epoxide+metabolites+in+nociceptive+signaling&amp;rft.volume=113-115&amp;rft.pages=2-12&amp;rft.date=2014&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4254344&amp;rft_id=info%3Apmid%2F25240260&amp;rft_id=info%3Adoi%2F10.1016%2Fj.prostaglandins.2014.09.001&amp;rft.aulast=Wagner&amp;rft.aufirst=K&amp;rft.au=Vito%2C+S&amp;rft.au=Inceoglu%2C+B&amp;rft.au=Hammock%2C+B.+D.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4254344&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxydocosapentaenoic+acid\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n</ol></div></div>\n\n<!-- \nNewPP limit report\nParsed by mw1270\nCached time: 20180908221203\nCache expiry: 1900800\nDynamic content: false\nCPU time usage: 0.196 seconds\nReal time usage: 0.215 seconds\nPreprocessor visited node count: 909/1000000\nPreprocessor generated node count: 0/1500000\nPost\u2010expand include size: 33926/2097152 bytes\nTemplate argument size: 90/2097152 bytes\nHighest expansion depth: 7/40\nExpensive parser function count: 0/500\nUnstrip recursion depth: 0/20\nUnstrip post\u2010expand size: 28357/5000000 bytes\nNumber of Wikibase entities loaded: 0/400\nLua time usage: 0.091/10.000 seconds\nLua memory usage: 3.05 MB/50 MB\n-->\n<!--\nTransclusion expansion time report (%,ms,calls,template)\n100.00%  156.179      1 Template:Reflist\n100.00%  156.179      1 -total\n 78.22%  122.164     14 Template:Cite_journal\n  1.18%    1.841      1 Template:Main_other\n-->\n\n<!-- Saved in parser cache with key enwiki:pcache:idhash:49599350-0!canonical and timestamp 20180908221203 and revision id 776740264\n -->\n</div>"},"langlinks":[],"categories":[{"sortkey":"","*":"Metabolic_pathways"},{"sortkey":"","*":"Cytochrome_P450"},{"sortkey":"","*":"Docosanoids"},{"sortkey":"","*":"Fatty_acids"},{"sortkey":"","*":"Epoxides"},{"sortkey":"","*":"Cell_biology"},{"sortkey":"","*":"Immunology"},{"sortkey":"","*":"Inflammations"},{"sortkey":"","*":"Blood_pressure"},{"sortkey":"","*":"Human_physiology"},{"sortkey":"","*":"Animal_physiology"}],"links":[{"ns":0,"exists":"","*":"20-Hydroxyeicosatetraenoic acid"},{"ns":0,"exists":"","*":"Acylation"},{"ns":0,"exists":"","*":"Angiogenesis"},{"ns":0,"exists":"","*":"Arachidonic acid"},{"ns":0,"exists":"","*":"Autocrine"},{"ns":0,"exists":"","*":"Beta oxidation"},{"ns":0,"exists":"","*":"CYP1A1"},{"ns":0,"exists":"","*":"CYP1A2"},{"ns":0,"exists":"","*":"CYP2C18"},{"ns":0,"exists":"","*":"CYP2C19"},{"ns":0,"exists":"","*":"CYP2C8"},{"ns":0,"exists":"","*":"CYP2C9"},{"ns":0,"exists":"","*":"CYP2E1"},{"ns":0,"exists":"","*":"CYP2J2"},{"ns":0,"exists":"","*":"CYP2S1"},{"ns":0,"exists":"","*":"CYP4A11"},{"ns":0,"exists":"","*":"CYP4F12"},{"ns":0,"exists":"","*":"CYP4F8"},{"ns":0,"exists":"","*":"Cis\u2013trans isomerism"},{"ns":0,"exists":"","*":"Digital object identifier"},{"ns":0,"exists":"","*":"Diol"},{"ns":0,"exists":"","*":"Docosahexaenoic acid"},{"ns":0,"exists":"","*":"Double bond"},{"ns":0,"exists":"","*":"Eicosapentaenoic acid"},{"ns":0,"exists":"","*":"Enantiomer"},{"ns":0,"exists":"","*":"Enantiomers"},{"ns":0,"exists":"","*":"Epoxide"},{"ns":0,"exists":"","*":"Epoxyeicosatetraenoic acid"},{"ns":0,"exists":"","*":"Epoxyeicosatrienoic acid"},{"ns":0,"exists":"","*":"Epoxygenase"},{"ns":0,"exists":"","*":"Fish oil"},{"ns":0,"exists":"","*":"Isoforms"},{"ns":0,"exists":"","*":"Omega-3 fatty acid"},{"ns":0,"exists":"","*":"Omega-6 fatty acid"},{"ns":0,"exists":"","*":"Paracrine"},{"ns":0,"exists":"","*":"Phospholipase A2"},{"ns":0,"exists":"","*":"Phospholipid"},{"ns":0,"exists":"","*":"Polyunsaturated fatty acid"},{"ns":0,"exists":"","*":"PubMed Central"},{"ns":0,"exists":"","*":"PubMed Identifier"},{"ns":0,"exists":"","*":"Soluble epoxide hydrolase"},{"ns":0,"exists":"","*":"Structural isomer"},{"ns":0,"exists":"","*":"Vicinal (chemistry)"}],"templates":[{"ns":10,"exists":"","*":"Template:Reflist"},{"ns":10,"exists":"","*":"Template:Cite journal"},{"ns":10,"exists":"","*":"Template:Main other"},{"ns":828,"exists":"","*":"Module:Citation/CS1"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Configuration"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Whitelist"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Utilities"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Date validation"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Identifiers"},{"ns":828,"exists":"","*":"Module:Citation/CS1/COinS"},{"ns":828,"exists":"","*":"Module:Check for unknown parameters"}],"images":["Lock-green.svg"],"externallinks":["//doi.org/10.1124/pr.113.007781","//www.ncbi.nlm.nih.gov/pubmed/25244930","//www.ncbi.nlm.nih.gov/pmc/articles/PMC4314516","//doi.org/10.1016/j.bbalip.2014.07.020","//www.ncbi.nlm.nih.gov/pubmed/25093613","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3914417","//doi.org/10.1016/j.plipres.2013.11.003","//www.ncbi.nlm.nih.gov/pubmed/24345640","//doi.org/10.1089/ars.2014.6150","//www.ncbi.nlm.nih.gov/pubmed/25330284","//doi.org/10.1016/j.prostaglandins.2011.09.001","//www.ncbi.nlm.nih.gov/pubmed/21945326","//doi.org/10.1016/j.abb.2008.01.002","//www.ncbi.nlm.nih.gov/pubmed/18206980","//doi.org/10.1016/j.bbapap.2010.09.009","//www.ncbi.nlm.nih.gov/pubmed/20869469","//www.ncbi.nlm.nih.gov/pmc/articles/PMC2674692","//doi.org/10.1194/jlr.R800038-JLR200","//www.ncbi.nlm.nih.gov/pubmed/18952572","//doi.org/10.3109/03602532.2013.806537","//www.ncbi.nlm.nih.gov/pubmed/23865864","//www.ncbi.nlm.nih.gov/pmc/articles/PMC4031946","//doi.org/10.1194/jlr.M047357","//www.ncbi.nlm.nih.gov/pubmed/24634501","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3733540","//doi.org/10.1016/j.gene.2013.05.008","//www.ncbi.nlm.nih.gov/pubmed/23701967","//doi.org/10.1097/FJC.0b013e318273b007","//www.ncbi.nlm.nih.gov/pubmed/23011468","//doi.org/10.1111/1753-0407.12358","//www.ncbi.nlm.nih.gov/pubmed/26621325","//www.ncbi.nlm.nih.gov/pmc/articles/PMC4254344","//doi.org/10.1016/j.prostaglandins.2014.09.001","//www.ncbi.nlm.nih.gov/pubmed/25240260"],"sections":[{"toclevel":1,"level":"2","line":"Structure","number":"1","index":"1","fromtitle":"Epoxydocosapentaenoic_acid","byteoffset":1918,"anchor":"Structure"},{"toclevel":1,"level":"2","line":"Production","number":"2","index":"2","fromtitle":"Epoxydocosapentaenoic_acid","byteoffset":4042,"anchor":"Production"},{"toclevel":1,"level":"2","line":"EDP metabolism","number":"3","index":"3","fromtitle":"Epoxydocosapentaenoic_acid","byteoffset":10546,"anchor":"EDP_metabolism"},{"toclevel":1,"level":"2","line":"Clinical significance","number":"4","index":"4","fromtitle":"Epoxydocosapentaenoic_acid","byteoffset":13670,"anchor":"Clinical_significance"},{"toclevel":1,"level":"2","line":"References","number":"5","index":"5","fromtitle":"Epoxydocosapentaenoic_acid","byteoffset":15242,"anchor":"References"}],"parsewarnings":[],"displaytitle":"Epoxydocosapentaenoic acid","iwlinks":[],"properties":[{"name":"wikibase_item","*":"Q25304832"}]}}